Bristol Myers Squibb (BMY) Current Taxes (2009 - 2019)

Bristol Myers Squibb has disclosed Current Taxes across 11 years of filings, most recently posting $525.0 million for Q1 2019.

• In Q1 2019, Current Taxes rose 77.36% year-over-year to $525.0 million; the TTM figure through Mar 2019 stood at $525.0 million (up 77.36% YoY), while the FY2018 annual figure was $398.0 million, up 72.29% from the prior year.
• Current Taxes advanced to $525.0 million in Q1 2019, from $398.0 million in the prior quarter.
• Over the last five years, Current Taxes for BMY reached as high as $572.0 million in Q4 2015 and fell as low as $98.0 million in Q2 2015.
• The 5-year median for Current Taxes is $291.0 million (2017), against an average of $295.9 million.
• Annual changes were most pronounced in 2015 — Current Taxes soared 118.32% — and 2016, when it plunged 73.43%.
• A 5-year view of Current Taxes shows it stood at $572.0 million in 2015, then sank by 73.43% to $152.0 million in 2016, then soared by 51.97% to $231.0 million in 2017, then jumped by 72.29% to $398.0 million in 2018, then surged by 31.91% to $525.0 million in 2019.
• According to Business Quant data, Current Taxes over the past three periods registered $525.0 million, $398.0 million, and $355.0 million for Q1 2019, Q4 2018, and Q3 2018 respectively.